The 12 closest competitors and alternatives to OneSkin among biotech companies — ranked by similarity to what OneSkin actually does, not by market-cap band.
Subscribe to see OneSkin’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
OneSkin, Inc. is a for-profit biotechnology and cosmetics company operating in the beauty, health care, and personal care sectors. Recognized on Fast Company's Most Innovative Companies List in 2024, the company is headquartered in San Francisco, California.
OneSkin is a biotech company headquartered in United States. It has raised at least $52.9M across the 5 funding rounds on record. Its most recent funding round raised $20.4M in May 2025. Xcout tracks 3 named people at OneSkin, including Carolina Reis de Oliveira (President). Xcout recorded 2 job postings from OneSkin in the last 90 days, naming tools such as NetSuite.
At least $52.9M raised across the 5 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $20.4M | — | |
| SEC Form D filing | $7M | — | |
| SEC Form D filing | $12.4M | — | |
| SEC Form D filing | $626,594 | — | |
| Series A | $12.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 2 job postings from OneSkin in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see OneSkin's hiring signals →
Ranked by semantic similarity — how close each company is to OneSkin by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Outer Biosciences specializes in developing breakthrough bioactives for skin health by discovering novel components from underexplored natural sources using an advanced ex vivo platform. Headquartered in Malden, the company aims to improve human health and skin care through innovative biological research.
Biotechnology
One Biosciences is a biotechnology company headquartered in Paris, France. It is driven by innovative scientists and biotech leaders focused on advancing precision medicine and novel therapies for patients.
Biotechnology
Ankasa Regenerative Therapeutics, Inc. is a for-profit biotechnology company headquartered in South San Francisco, California.
Biotechnology
Geltor is an Emeryville, California-based biotechnology research company powered by its Biodesigner AI™ platform to create sustainable, animal-free specialty proteins for beauty, personal care, and nutrition markets.
Similar biotech company
Dermata Therapeutics, Inc. operates as a clinical-stage biotechnology enterprise, concentrating its efforts on discovering, advancing, and bringing to market novel pharmaceutical treatments designed to address various medical and cosmetic skin ailments. The company's principal experimental drug, DMT310, has successfully finished Phase IIb clinical trials for moderate-to-severe acne and completed a Phase Ib proof-of-concept study for mild-to-moderate psoriasis. Furthermore, DMT310 is presently undergoing Phase 2 clinical evaluation for moderate-to-severe rosacea. Dermata is also progressing with DMT410, which has concluded Phase Ib proof-of-concept trials aimed at managing hyperhidrosis and other aesthetic concerns. Established in 2014, the firm maintains its headquarters in San Diego, California.
Biotechnology
Checkerspot, Inc. is a for-profit active company specializing in innovation through biotechnology, such as healthy fats and oils from fermentation and bio-based cosmetic ingredients.
Similar biotech company
Onava is a biotechnology research company headquartered in San Carlos, California, focused on improving AI platforms that grow smarter with every program.
Biotechnology
Cypre Inc. is a biotechnology company headquartered in San Francisco, California, that develops 3D tumor models and oncology platforms for drug discovery.
Biotechnology
Aperture Therapeutics is a biotechnology research company founded in 2022 and headquartered in San Carlos, California. The company is building an innovative drug discovery platform that leverages patient genetic diversity and mechanistic insights.
Biotechnology
Standard Model Biomedicine is a biotechnology research company based in San Francisco, United States. The company is focused on developing a foundation model for human biology to advance biomedical research.
Biotechnology
Adynxx, Inc. is a clinical-stage biopharmaceutical company headquartered in San Francisco, California, focused on biotechnology research and drug development.
Similar biotech company
International Stem Cell Corporation (ISCO) is a clinical-stage biotechnology firm dedicated to creating therapeutic and biomedical solutions for a global market, spanning North America, Asia, Europe, and beyond. Central to its offerings are products derived from its proprietary human parthenogenetic stem cells, a unique form of pluripotent stem cells. ISCO is actively engaged in developing specialized cell types, such as neural stem cells, which hold promise for treating Parkinson's disease and other disorders affecting the central nervous system. Beyond therapeutics, the company also develops, manufactures, and commercializes anti-aging skincare products and an extensive range of human cell culture products. Its diverse portfolio of human cell culture products serves as vital research tools across numerous scientific disciplines. This includes specialized cells and reagents designed for studying: Dermatology: Skin diseases, toxicology, and wound healing. Cardiovascular & Oncology: Heart and blood vessel conditions, and various cancers. Respiratory: Bronchial and tracheal conditions, toxicity, cystic fibrosis, asthma, and pathogenesis. Reproductive & Urological: Prostate, renal, bladder, corneal, and female reproductive system diseases, as well as general cellular physiology. Musculoskeletal & Metabolic: Skeletal muscle biology, diabetes, insulin pathways, muscle repair, and myotube development. The company also provides adult stem cells for regenerative medicine research and a full complement of reagents and supplements essential for cell growth, staining, and cryopreservation. Distribution of ISCO's skincare range occurs via its website and specialized professional channels, while its human cell culture products reach customers through a dedicated sales force, original equipment manufacturer (OEM) partners, and authorized brand distributors. Established in 2001, International Stem Cell Corporation maintains its headquarters in San Diego, California.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for OneSkinand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →